Preclinical Evaluation of ISH0339, a Tetravalent Broadly Neutralizing Bispecific Antibody Against SARS-CoV-2 with Long-Term Protection.
Antibody therapeutics(2023)
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined